LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 140 filers reported holding LEGEND BIOTECH CORP in Q1 2022. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,677,961 | +67.7% | 129,194 | +72.3% | 0.01% | +100.0% |
Q2 2023 | $5,174,972 | -24.8% | 74,967 | -47.5% | 0.00% | -40.0% |
Q1 2023 | $6,879,548 | +81.8% | 142,670 | +88.2% | 0.01% | +66.7% |
Q4 2022 | $3,784,186 | -28.6% | 75,805 | -41.6% | 0.00% | -25.0% |
Q3 2022 | $5,301,000 | -26.0% | 129,914 | -0.2% | 0.00% | -33.3% |
Q2 2022 | $7,160,000 | +94.5% | 130,196 | +28.5% | 0.01% | +500.0% |
Q1 2022 | $3,682,000 | +57.6% | 101,302 | +102.1% | 0.00% | 0.0% |
Q4 2021 | $2,336,000 | +196.4% | 50,114 | +221.8% | 0.00% | – |
Q3 2021 | $788,000 | +147.8% | 15,571 | +101.1% | 0.00% | – |
Q2 2021 | $318,000 | +2346.2% | 7,743 | +1594.3% | 0.00% | – |
Q1 2021 | $13,000 | -27.8% | 457 | -28.6% | 0.00% | – |
Q4 2020 | $18,000 | – | 640 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FengHe Fund Management Pte. Ltd. | 997,714 | $36,257,000 | 13.28% |
JOHNSON & JOHNSON | 1,629,173 | $59,204,000 | 11.19% |
Paradigm Biocapital Advisors LP | 831,728 | $30,225,000 | 7.99% |
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,100,542 | $39,994,000 | 5.54% |
HHLR ADVISORS, LTD. | 6,936,617 | $252,077,000 | 5.26% |
Old Well Partners, LLC | 79,700 | $2,896,000 | 1.94% |
Parkman Healthcare Partners LLC | 120,473 | $4,378,000 | 1.28% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 4,500 | $5,632,000 | 1.27% |
AtonRa Partners | 50,928 | $1,851,000 | 1.00% |
Avidity Partners Management LP | 1,095,000 | $39,792,000 | 0.83% |